Key Market Indicators
Slovene antacid medicine sales are expected to hit $1.6 million by 2026, according to a recent report. This is a 3.2% increase year-over-year from the $1.3 million in sales in 2021. Since 2012, the Slovene market has seen a 10.5% year-over-year rise. In 2021, Slovenia came in 15th place, with Canada overtaking it with $1.3 million in sales. Italy, Germany, and Chile respectively were second, third, and fourth in the ranking.
